Virtual MD Anderson Proton Therapy Training Webinar - Pelvic

---

LIVE

Friday, September 10, 2021, 9:00 AM - 12:30 PM, Online


AMA PRA Category 1 Credits™ (2.75 hours), Non-Physician Attendance (2.75 hours)

Since 2006, the MD Anderson Proton Therapy Center in Houston has treated more than 10,000 patients with the most advanced radiation treatment available. Proton therapy has allowed MD Anderson to treat cancer with power and precision while sparing healthy tissue and reducing the risk of side effects during and following treatment. MD Anderson has published more than 570 manuscripts on proton therapy and is currently running numerous clinical trials to define the value of proton therapy. We are the first in North America to treat patients with Intensity-Modulated Proton Therapy (IMPT) and continue to pioneer in the treatment of each disease site using IMPT.

MD Anderson is well positioned to educate and expand the global knowledge in the developing field of proton therapy. As the medical industry, insurance companies and the public become more aware of the benefits of utilizing proton therapy, there remains a gap in the knowledge in this field of treatment as proton therapy expands rapidly both nationally and internationally. Proton therapy is very different from photon therapy and the goal of the MD Anderson Proton Therapy Training Program is to bridge this knowledge gap by teaching the value of proton therapy by disease site. Our Proton Therapy Training Program aims to provide the knowledge and expertise to physicians, physicists, dosimetrists, therapists and administrators who are planning to treat patients with IMPT.

 

1. Incorporate the skills learned through interactive virtual sessions to better prepare for proton therapy treatments, thus improving patient outcomes
2. Incorporate knowledge on the responsibilities of physicians, physicists, dosimetrists and therapists in the treatment of proton therapy and the importance of their roles to provide optimal patient care.Incorporate knowledge on the responsibilities of dosimetrists, physicists and nurses in the treatment of proton therapy and the importance of their roles to provide optimal patient care
3. Apply the knowledge of treatment planning and clinical operations to perform proton therapy in respective centers/locations
4. Gain a greater appreciation and perspective of the steps and personnel needed to perform quality proton therapy

Please join us for an interactive virtual experience with world-renowned experts specializing in treating pelvic tumors with proton therapy. This course should be of interest to radiation oncologists, medical physicists, dosimetrists, therapists, scientists, trainees, administrators and any health system interested in proton therapy.

For questions or more information, please contact Rola Georges at [email protected].

Registration fees:
Physicians – $100
Physicists – $75
Dosimetrists, Radiation Therapists – $50 
Residents and Fellows – free, pending a verification letter from their Chairperson sent to [email protected].

To register please visit: https://www.engagez.net/PelvicProtonTherapyTrainingWebinar#lct=entrance

For additional information, please visit:  
https://www.mdanderson.org/patients-family/diagnosis-treatment/care-centers-clinics/proton-therapy-center/for-physicians/proton-therapy-training-webinars.html

The University of Texas MD Anderson Cancer Center designates this live activity for a maximum of 2.75 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

View the accessibility policy for The University of Texas M.D Anderson Cancer Center.

 

The University of Texas MD Anderson Cancer Center complies with all requirements of the identified accrediting body  (ACCME, ANCC, ACPE). Disclosure of speakers, faculty members, planning committee members and their commercial relationships will be shared with learners prior to the educational activity.

Mitigation of Relevant Financial Relationships

The University of Texas MD Anderson Cancer Center adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Friday, September 10, 2021

The symposium organizing committee wishes to express appreciation to the following companies:

RaySearch Americas

Varian Medical Systems